Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Shionogi & Co. Ltd.

Maze Finds A Way As Shionogi Signs On To Develop Pompe Drug

Months after an antitrust lawsuit challenged its deal with Sanofi and raised uncertainty about the future of MZE001, Maze secured a new partner for potentially the first oral Pompe disease drug.

Deals Business Strategies

Shionogi: Other Countries Must Follow UK’s Lead On Antimicrobial Incentives

Shionogi’s UK general manager praised NHS England’s novel subscription model for antibiotics, but warned the country would be “wasting money” unless other global regulators introduced similar incentives for antimicrobial development.

Europe International

Chinese Firms Up Their Game In Novel Flu Antiviral Development

Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.

China Research & Development

Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings

Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.

Japan Pricing Debate
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
  • Biotechnology
    • Drug Discovery Tools
  • Other Names / Subsidiaries
    • Shionogi Healthcare Co., Ltd
    • Shionogi Pharma Co., Ltd
    • Shionogi Techno Advance Research Co., Ltd.
    • Shionogi Administration Service Co., Ltd.
    • Shionogi Business Partner Co., Ltd
    • Shionogi Marketing Solutions Co., Ltd
    • Shionogi Career Development Center Co., Ltd.
    • Shionogi Digital Science Co., Ltd.
    • Shionogi Pharmacovigilance Center Co., Ltd.
    • Aburahi AgroResearch Co., Ltd.
    • Shionogi Smile Heart Co., Ltd
    • UMN Pharma Inc.
    • Shionogi B.V.
UsernamePublicRestriction

Register